153 related articles for article (PubMed ID: 26096942)
21. Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells.
Ham S; Kim KH; Kwon TH; Bak Y; Lee DH; Song YS; Park SH; Park YS; Kim MS; Kang JW; Hong JT; Yoon DY
Oncol Rep; 2014 Jun; 31(6):2683-91. PubMed ID: 24789165
[TBL] [Abstract][Full Text] [Related]
22. S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
Tong D; Qu H; Meng X; Jiang Y; Liu D; Ye S; Chen H; Jin Y; Fu S; Geng J
Oncol Rep; 2014 Sep; 32(3):1124-32. PubMed ID: 24970681
[TBL] [Abstract][Full Text] [Related]
23. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
Choedon T; Dolma D; Kumar V
J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.
Krohne TU; Shankara S; Geissler M; Roberts BL; Wands JR; Blum HE; Mohr L
Hepatology; 2001 Sep; 34(3):511-8. PubMed ID: 11526536
[TBL] [Abstract][Full Text] [Related]
25. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line.
Chang J; Hsu Y; Kuo P; Kuo Y; Chiang L; Lin C
Life Sci; 2005 Mar; 76(16):1883-93. PubMed ID: 15698865
[TBL] [Abstract][Full Text] [Related]
26. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cell growth and induction of G1-phase cell cycle arrest in hepatoma cells by steroid extract from Meretrix meretrix.
Wu TH; Yang RL; Xie LP; Wang HZ; Chen L; Zhang S; Zhao Y; Zhang RQ
Cancer Lett; 2006 Feb; 232(2):199-205. PubMed ID: 16458116
[TBL] [Abstract][Full Text] [Related]
28. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
29. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
Pulukuri SM; Rao JS
Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
[TBL] [Abstract][Full Text] [Related]
30. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells.
Hsu YL; Kuo PL; Lin CC
Life Sci; 2005 Jun; 77(3):279-92. PubMed ID: 15878356
[TBL] [Abstract][Full Text] [Related]
31. Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway.
Wang CC; Chiang YM; Kuo PL; Chang JK; Hsu YL
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1301-8. PubMed ID: 18671724
[TBL] [Abstract][Full Text] [Related]
32. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
34. Physalis peruviana extract induces apoptosis in human Hep G2 cells through CD95/CD95L system and the mitochondrial signaling transduction pathway.
Wu SJ; Ng LT; Lin DL; Huang SN; Wang SS; Lin CC
Cancer Lett; 2004 Nov; 215(2):199-208. PubMed ID: 15488639
[TBL] [Abstract][Full Text] [Related]
35. Darbepoetin inhibits proliferation of hepatic cancer cells in the presence of TGF-β.
Ehnert S; Freude T; Eicher C; Burkhardt B; Martínez Sánchez JJ; Neumann J; Mühl-Benninghaus R; Dooley S; Pscherer S; Nussler AK
Arch Toxicol; 2014 Jan; 88(1):89-96. PubMed ID: 23877120
[TBL] [Abstract][Full Text] [Related]
36. Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system.
Okazaki T; Sakamuro D
J Cancer Res Clin Oncol; 2007 Sep; 133(9):581-8. PubMed ID: 17505842
[TBL] [Abstract][Full Text] [Related]
37. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice.
Wang GY; Lv QH; Dong Q; Xu RZ; Dong QH
J Asian Nat Prod Res; 2009; 11(3):219-28. PubMed ID: 19408145
[TBL] [Abstract][Full Text] [Related]
38. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
Selvendiran K; Koga H; Ueno T; Yoshida T; Maeyama M; Torimura T; Yano H; Kojiro M; Sata M
Cancer Res; 2006 May; 66(9):4826-34. PubMed ID: 16651438
[TBL] [Abstract][Full Text] [Related]
39. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
[TBL] [Abstract][Full Text] [Related]
40. Tetrazolium violet inhibits cell growth and induces cell death in C127 mouse breast tumor cells.
Zhao YF; Kong QZ
Chem Biol Interact; 2008 Jul; 174(1):19-26. PubMed ID: 18547555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
